American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · Aug 2018
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
Multidrug-resistant tuberculosis (MDR-TB) is a major burden to public health in Europe. Reported treatment success rates are around 50% or less, and cure rates are even lower. ⋯ Conventional standard MDR-TB treatment regimens resulted in a higher frequency of failure compared with individualized treatments. Overall, cure from MDR-TB is substantially more frequent than previously anticipated, and poorly reflected by World Health Organization outcome definitions.